Objectives: Classical methods for combining summary data from genome-wide association studies (GWAS) only use marginal genetic effects and power can be compromised in the presence of heterogeneity. We aim to enhance the discovery of novel associated loci in the presence of heterogeneity of genetic effects in sub-groups defined by an environmental factor. 2 5
INTRODUCTION
Genome-wide association studies (GWAS) are popular epidemiologic tools for studying the genetic 4 5 architecture underlying a phenotypic trait [1] . Meta-analysis is a commonly used approach to combine genetic associations across multiple independent studies [2] . Fixed effect meta-analysis based on summary statistics is known to retain full efficiency of an analysis based on individual level data [3] .
More recently, methods for aggregating association signals across multiple related phenotypes have also become more popular [4, 5] . 5 0
The association analysis based on subsets (ASSET) test, proposed by Bhattacharjee et al. [6] , uses summary statistics from individual association analysis to develop a powerful test that allows the existence of both a subset of null results and effects in opposite directions in different individual tests. This approach essentially explores all possible non-empty subsets of available studies/traits and 5 5
searches for the one that yields the strongest evidence of association while adjusting for multiple testing during such exhaustive search. One appealing feature of ASSET is that the most probable subset of studies/traits that exhibit genetic association can be identified in addition to the enhancement of power of detecting association signals. This method has been widely used in analyses of associations across multiple studies and phenotypes [7, 8] . 6 0
Exploiting gene-environment (G-E) interaction may help identify genetic variants that do not demonstrate very strong marginal effects due to environmental heterogeneity but may have stronger genetic effects in sub-groups defined by certain levels of an exposure [9] [10] [11] [12] . Like most commonly used methods that screen only for marginal associations, ASSET does not account for potential G-E 6 5 interactions in the testing procedure. If a genetic variant only affects a subgroup, for example the exposed group, then in the presence of such pure G-E interaction, the power of ASSET can be largely compromised. Several existing versions of 2-degree-of-freedom (2-df) tests for discovering genetic associations take G-E interactions into account. Kraft et al. [11] proposed a likelihood ratio test that jointly tests for genetic main effects and G-E interactions in case-control studies. Dai et al. [10] 7 0
proposed a slightly different approach that is based on the sum of two Wald chi-square statistics for detecting marginal effects combined with G-E interactions. The latter approach has the advantage of incorporating G-E independence into the test statistic for G-E interaction in case-control studies to achieve increased power [13, 14] . The literature on meta-analysis of G-E interactions or joint tests remains relatively limited [15] [16] [17] , and none of these approaches attempt to specifically identify a 7 5 subset of studies/traits that are most likely to have genetic associations and/or interactions. Current literature shows that the 2-df tests mentioned above can offer enhanced power in the presence of G-E interactions and do not lead to significant loss of power even when the interactions are absent [15, 17] .
In this paper, we propose a modification to ASSET that incorporates G-E interactions to increase the 8 0 power of detecting genetic associations in combining summary data across studies of a given phenotype (say type 2 diabetes) or across multiple related phenotypes (say a set of lipid traits) measured in different studies. Our approach is similar to ASSET in terms of searching over all possible combinations of studies/phenotypes and thus inherits its advantage of identifying the maximally associated subset along with increased power for detecting the overall associations. The proposed 8 5 framework uses p-values from the underlying tests as input instead of ܼ -statistics that are used by ASSET, and is therefore referred to as p-value Assisted Subset Testing for Associations (pASTA). To be able to incorporate G-E interactions, pASTA uses 2-df tests as the underlying test statistics to be combined. In fact, the p-values can result from any statistical tests, including tests with multiple degrees of freedom. On the other hand, by using p-values, one loses the ability to incorporate the signs 9 0 of coefficients (for both genetic main effect and G-E interaction) and the method is intrinsically twosided. Since the key input variables are the p-values from underlying tests, pASTA can be used under any commonly used epidemiologic study design and we present our simulation studies and data examples for both case-control and cohort studies. Like ASSET, the analytical method in pASTA can handle a set of correlated p-values, enabling its validity in studies with overlapping subjects or multiple 9 5 phenotypes measured on the same set of subjects.
The rest of the paper is organized as follows. We first describe the construction of our test statistic and derivation of the associated p-value. We present extensive simulation studies to compare the performance of our proposed method to ASSET and Fisher's combined p-value approaches [18] with 1 0 0 and without G-E interactions under various parameter settings. Specifically, we examine the type I error rates and the power to detect (1) the truly associated variant and (2) the truly associated subset of studies/traits for the given variant. We illustrate our proposed method with two data applications. The first is a meta-analysis of six case-control studies of type 2 diabetes (T2D) among European population, with 4,422 cases and 5,202 controls. We focus on two single nucleotide polymorphisms (SNPs) in the 1 0 5
FTO gene (MIM 610966) related to obesity and their interactions with body mass index (BMI). The second application is a multiple-phenotype analysis of nine lipid-related quantitative traits using data of 5,123 individuals from the North Finland Birth Cohort 1966 (NFBC1966) Study. We investigate the association between two SNPs discovered by GWAS, one near the LPL gene (MIM 609708) and the other in the APOB gene (MIM 107730), and the nine lipid traits while taking the SNP-BMI 1 1 0 interactions into consideration. We conclude the paper with a discussion.
MATERIAL AND METHODS

Notation
We consider ‫ܭ‬ studies, each with sample size ݊ . We allow the studies to have a set of overlapping 1 Supplemental Table S1 . The test of the form MA+GE is typically the sum of two Wald chi-square test 1 3 5
statistics that are known to be asymptotically independent and can thus be combined to yield a 2-df chi-square statistic [19] .
For a case-control study, the coefficient of interaction in a closed form, especially when the number of studies ‫ܭ‬ is large. Therefore, we borrow the idea followed in ASSET and use the discrete 1 6 5 local maxima (DLM) procedure [20] to obtain a conservative upper bound for the meta-analytic combined p-value. The DLM procedure automatically accounts for the multiple comparison issue. The detailed derivation of the combined p-value based on 
. This DLM-based p-value is actually an 1 7 5
upper bound to the exact one (Equation A1 in Appendix). Hence the overall procedure is conservative in terms of type I error.
Each of the terms of the form 
Under the null hypothesis,
Several methods have been proposed to estimate the correlation matrix Σ . Lin and Sullivan ( [21] provided a formula to estimate the correlation between a pair of studies using the information of shared 1 9 5 cases and controls when the number of overlapping subjects is known. They also discussed a modified version of the formula for quantitative traits in a cross-sectional study. Bhattacharjee et al. [6] extended Lin and Sullivan's formula for case-control studies to accommodate the situation where cases of one study serves as controls of another. However, these estimates will likely be inaccurate when the overlap fraction is large, and therefore do not directly apply to multiple-phenotype analysis, where the 2 0 0 phenotypes are measured on the same set of subjects and the overlap fraction is 100%. In this case, since large positive values of phenotypic measurements usually indicate strong positive genetic associations and thus large positive ܼ -statistics, an intuitive way to approximate the correlations of ܼ 's is to use the phenotypic correlations [22], as is done in ASSET. We adopt this approach for our simulation studies and the second data example to estimate the correlation matrix
In other words, if
Comparison of pASTA and ASSET
We would like to point out a few features of pASTA as compared to ASSET when one is only interested in marginal genetic association estimated by Model 1. First, ASSET and pASTA use the ܼ -2 1 0 statistics in different ways (Table S2 ). The For the latter case, ASSET searches for the subsets of studies that yield the strongest evidence separately in both directions. It obtains a p-value for each direction, and combines 2 1 5 the two p-values using Fisher's combined p-value method [18] . pASTA does not have this feature. A more detailed comparison of the ܼ -statistics, test statistics and analytic expression for the DLM-based p-values of the two methods are presented in Table S2 . The extension in this paper is mainly to incorporate interaction while testing association using 2-df tests in the ASSET framework via the use of p-values.
Simulation studies
Simulation Study 1: Combining Signals Across Multiple Independent Case-Control Studies
Methods Considered. We first assess the performance of the proposed pASTA approach for combining summary results from multiple independent case-control studies that have no overlapping 2 2 5 subjects or relatedness. We compare pASTA to three classes of alternatives (Table 1) : ASSET, Fisher's combined p-value method [18] , and the gold standard test which assumes that the true subset of non-null studies and the true model from which the data are generated are known a priori, to reflect the maximum achievable power for benchmarking each method. Given global null. Bhattacharjee et al. [6] has already compared inverse-variance weighted meta-analysis with ASSET and Fisher's method, showing that the former is not as powerful as the latter two. Therefore, we do not include standard fixed effect inverse-variance weighted meta-analysis method in our comparative study. We use several choices of 2 df tests as described in Table 2 and expanded in 
We consider two scenarios (Table S3 ), one with no environmental factor and hence no G-E interaction and the other with
. All ten studies share the same parameters 2 5 0 in each scenario (Table S3 ). We evaluate the type I errors at three levels of significance: Metrics for Power Analysis. We compare the power of pASTA with the other methods displayed in Table 1 from two perspectives: the power of detecting overall genetic associations and the accuracy of . The specific definitions of the two metrics are given in Appendix. We also report the sensitivity and specificity of identifying the subset of non-null studies, defined as the proportion of non-null studies that are correctly identified by subset-based approaches, and the proportion of truly null studies that are declared null, respectively. We use
as the significance level, which resembles a candidate gene study with 50 SNPs, and repeat the simulation 2,000 times for each parameter configuration.
Power for Detecting Association After Incorporating Interaction. We then consider both ‫ܩ‬ and ‫ܧ‬ in our model and the whole set of 1-df and 2-df tests as listed in Table 1 . We consider five scenarios (Table S4) 
Simulation Study 2: A Multiple-Phenotype Analysis in a Cohort Study
Methods Considered. We compare the performance of pASTA and ASSET in a cohort study with a set of multiple correlated traits. 
. We use the empirical phenotypic correlations from the NFBC1966 study (Table S5) (Table S6 ). The power of these subset-based 3 0 0 approaches are evaluated in two scenarios (Table S7 ) using the same metrics as used in Simulation Study 1. In Scenario 1, no interaction is involved, while in Scenario 2, interaction comes into play.
Data Analyses
We illustrate our methods by using data from two genetic association studies. The first is a meta-3 0 5
analysis of six independent case-control studies of T2D and the other considers a multiple-phenotype analysis of nine quantitative lipid-related traits measured on a population-based cohort. In both examples, we compare the performance of pASTA with other competing methods as described in Table 1 . investigated the associations of T2D and two SNPs in the FTO gene, rs6499640 and rs1121980, respectively after taking into account potential interaction effects with BMI. These two SNPs were chosen as candidates because they showed significant interactions with BMI in a previous study [25] .
Descriptive statistics of the six studies are summarized in Supplemental Table S8 . In particular, the total sample size of the six studies was 9,624, with 4,422 cases and 5,202 controls. Sample sizes of the 3 2 0 six studies vary from 1,058 to 2,219 and the case to control ratios vary from 0.37 to 1.75. The minor allele frequencies (MAF) of rs6499640 and rs1121980 in controls range from 0.37 to 0.43 and 0.39 to 0.48, respectively, across the studies. 
and Model 4 were fitted separately to the six studies. Then the various meta-analysis methods were applied to the summary statistics. Note that the METSIM study only contains male subjects, so 3 3 5
the sex indicator was removed from the two models for this study.
Application to the North Finland Birth Cohort 1966 Study
We obtained the genotype and phenotype data of the NFBC1966 study from dbGaP with accession number phs000276.v2.p1. The NFBC1966 data contain 5,402 individuals and 364,590 SNPs, with 3 4 0 multiple metabolic traits measured on subsets of individuals. Among these traits, we considered nine quantitative traits in the present study as phenotypes: C-reactive protein (CRP), glucose, insulin, total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides (TG), systolic blood pressure (SBP), and diastolic blood pressure (DBP). Body mass index (BMI) was the environmental factor of interest. Following previous studies [26, 27] we excluded individuals with 3 4 5
missing phenotype data or having discrepancies between reported sex and sex determined from the X chromosome. We excluded SNPs with a minor allele frequency less than 1%, having missing values in more than 1% of the individuals, or with a Hardy-Weinberg equilibrium p-value below 1 0 ି ସ . This left us with 5,123 individuals and 319,147 SNPs. For each phenotype in turn, we quantile transformed the phenotypic values to a standard normal distribution, regressed out sex, oral contraceptives and 3 5 0 pregnancy status effects [26] , and quantile transformed the residuals to a standard normal distribution again. We replaced the missing genotypes for a given SNP with its mean genotype value. To account for potential relatedness in the Finnish population one can use a kinship matrix in a linear mixed model to account for population admixture. As an alternative, we find that using linear regression models with principal components (PCs) as covariates also effectively controls for population stratification in 3 5 5 the data. For example, with ten PCs, the genomic control factors for the ten phenotypes ranged from 0.96 to 1.01, with a median value of 0.99. Therefore, we extracted the top ten PCs from the genotype matrix as covariates to control for potential population stratifications. SNPs in the data. Then for each SNP we calculated the meta-analytic p-values using ASSET and pASTA, respectively. Correlations among the resultant ܼ -statistics of the nine phenotypes were estimated using observed phenotypic correlations.
The linear regression model with G-E interaction is specified as
After the genome-wide screening using the nine phenotypes separately, we performed another 3 7 0 genome-wide association analysis by analyzing all ten traits jointly with the multivariate linear mixed model implemented in GEMMA [28, 29] and compared the results of the two GWAS. We then selected the top 100 SNPs that showed the strongest associations for subsequent interaction analysis. We performed SNP-BMI interaction analysis on these 100 SNPs. 
Results
Simulation Study 1: Combining Signals Across Multiple Independent Case-Control Studies
Type I Error
In both scenarios, empirical type I error rates at thresholds ). This has been noted in previous studies of EB-type adaptive methods [14] .
Power Comparisons of ASSET and pASTA Based on 1-df Tests for Marginal Genetic Association 3 8 5
We extensively investigate how pASTA(MA) performs compared to ASSET when no environmental factors are considered (i.e. data generated under Model 1). The power of pASTA to detect overall genetic associations is almost the same as that of ASSET as the odds ratio of the marginal genetic effects varies, regardless of the directions of the genetic effects (Figures S1A, S1E). However, there is an observable difference in their accuracy of determining the exact subset of non-null studies for both 3 9 0 scenarios (Figures S1B, S1F). When the marginal genetic effects of non-null studies exist in the same direction (in this case positive direction), the accuracy of pASTA to determine the correct subset increases as the signal grows stronger, and reaches an empirical power of 0.72 as the odds ratio goes up to 1.2. However, two-sided ASSET is rarely able to identify the exact true subset, and the corresponding power stays around zero as the odds ratio varies. The main reason for such low accuracy 3 9 5
is that two-sided ASSET searches for associated subset in both positive and negative directions, in a subset of studies, the log odds ratios in the truly null studies are likely to be estimated as negative, and thus some null studies will be selected by two-sided ASSET. When the associations exist in opposite directions, two-sided ASSET has improved power to identify the correct subset of studies, but pASTA still consistently outperforms ASSET (Figures S1B, S1F). For both scenarios, the sensitivity of ASSET consistently stays higher than that of pASTA, while the specificity of ASSET is relatively low 4 0 5
(Figures S1C, S1D, S1G, S1H). These results are intuitively reasonable, since sensitivity is the proportion of non-null studies that are correctly identified and does not require that the exact subsets to be identified. When all of the ten studies are non-null ( Figure S2A ), pASTA is as powerful as ASSET in detecting signals of marginal associations, and only slightly less powerful than Fisher's method when the odds 4 1 0 ratio of marginal genetic effects is small (<1.1).
Power Comparison of All Methods with Data Generated under Model 2
Detection of Association.
We consider five scenarios (Table S4 ) to evaluate the power of detecting overall genetic associations. When there exists only marginal genetic effect but no G-E interaction 4 1 5 (Scenario 1), 1-df methods are slightly more powerful in discovering the overall associations than 2-df methods when the number of non-null studies ݇ 5
. For example, pASTA(JOINT) reaches a power of 0.85 when four out of the ten studies are non-null, which is 9.1%, 7.1%, and 9.9% lower than the power of Fisher's(MA), ASSET, and pASTA(MA), respectively ( Figure 1A) . This loss of power results from a penalty of the additional degree of freedom incorporated in the testing procedure in the 4 2 0 absence of G-E interaction. In Scenario 2, when G-E interaction exists and marginal genetic effect is moderate, all 2-df methods provide substantial power gain over 1-df methods ( Figure 1B standard test has the second best performance with the power being 0.61 when ݇ ൌ 7
. All 1-df methods barely detect any signals ( Figure 1C ). When the marginal association is nearly null but subgroup effects of genetic factor present in opposite directions in the exposed and unexposed group . All 1-df methods fail to detect the associations ( Figure 1D ). In a much less common situation where "cross-over" interaction exists (Scenario 5), the empirical power curves show a similar trend ( Figure 1E) being constantly around 0.4 ( Figure 1F ). The sensitivity of the subset-based methods, whether they are 1-df or 2-df, are close to one another as the number of non-null studies varies, and all of the methods are able to identify more than 80% of the non-null studies ( Figure S3A ). The specificity of ASSET is much smaller than that of the other subset-based methods based on pASTA ( Figure S3F) . When G-E interaction comes into play (Scenario 2-5), pASTA(MA+EB) performs the best in identifying the exact 4 4 5 subset and has both the highest sensitivity and specificity across the four scenarios. In particular, in Scenario 4 where the genetic variant has opposite effects on exposed and unexposed groups, the highest empirical probability of pASTA(MA+EB) to select the correct non-null studies is 0.46 when three out of the ten studies are non-null. pASTA(JOINT) and pASTA(MA+CC) have the second-best performance in terms of determining the exact subset of non-null studies as well as sensitivity and 4 5 0 specificity across Scenarios 2-5. It is noteworthy that in all five scenarios, the specificity of ASSET is the lowest among the subset-based methods, which indicates that ASSET tends to give more false positives of non-null studies than pASTA.
Simulation Study 2: A Multiple-Phenotype Analysis in a Cohort Study 4 5 5
Type I Error
The results of the type I error rates are presented in Table 2 . In general, the type I error rates of all methods tend to be conservative at all thresholds under evaluation. The only exception is that pASTA(JOINT) yields a type I error of 
Power Comparison
Detection of Association. Figure 2A reveals that in the absence of interaction, pASTA(MA) outperforms the other two methods when over five out of the nine traits have genetic associations. The identifying the exact subset of non-null traits are constantly close to 0 in both scenarios (Figures 2B,   2F ). In Figures 2C and 2G , the sensitivity of the pASTA approaches is close to one another and stays above 0.8 as the number of non-null traits varies, which indicates that these methods are able to identify over 80% of the non-null traits in one study. On the other hand, the sensitivity of ASSET decreases as the number of non-null traits increases. The curves of specificity ( Figures 2D, 2H) Supplemental Table S9 . The EB estimates of the interaction terms and their associated We then meta-analyzed the results from the six studies by applying all methods in Table 1 , and we present the results of the eight methods in Table 3 . For SNP rs6499640, all 1-df methods give insignificant p-values for marginal genetic associations with T2D at the level of 0.05. As for 2-df methods, pASTA(JOINT) gives the smallest p-value (p=0.008), and pASTA(MA+CC) give a slightly 4 9 5
higher p-value (p=0.009). The result of pASTA(MA+EB) is not statistically significant (p=0.090), which may be due to the presence of G-E correlation in this example. All 2-df pASTA methods identify D2D2007 and FUSION S2 as the non-null studies, which is consistent with what we observe from the results of 2-df tests for each study separately. We also investigated the odds ratios of T2D across different levels of BMI by fitting a logistic regression adjusting for age, gender, and the studies 5 0 0 to which the subjects belong. Supplemental Figure S4 shows that the marginal odds ratio for the SNP rs6499640 is close to 1, but when G-E interaction is taken into account, this SNP reveals a significant protective effect at the level of 0.05 when BMI equals 20 and 25. When BMI equals 30, the odds ratio of T2D becomes positive and is significantly different from the one when BMI equals 20.
0 5
When there is no evidence for G-E interactions in individual studies, as with SNP rs1121980, all 2-df methods fail to detect the overall genetic associations, but the p-values obtained from 2-df pASTA are smaller than those from 2-df Fisher's p-value combined methods. Furthermore, the p-value given by pASTA(MA) (p=0.024) is smaller than those of Fisher's(MA) (p=0.080) and ASSET (p=0.031).
pASTA also provides more plausible subset identification than ASSET when there are only significant 5 1 0 marginal genetic effects. In addition to FUSION S2 and HUNT as identified by all pASTA methods, ASSET also includes D2D2007, METSIM, and TROMSO as associated studies, whose p-values with respect to marginal associations in study-specific analysis (Table S9 ) are far from significant. This data analysis demonstrates that without sacrificing much efficiency in the absence of G-E interaction, pASTA provides potential power gain when marginal genetic effects are modest and interactions are 5 1 5
involved. Moreover, pASTA yields a more plausible subset of non-null studies.
Application 2: North Finland Birth Cohort 1966 Data
We performed a genome-wide multiple-phenotype analysis by applying pASTA and ASSET to the lipid-related traits in the NFBC1966 study. Supplemental Table S10 presents the SNPs whose meta- SNPs as the genome-wide significant SNPs, and the only overlapping SNP between the two sets is rs754524, which is located in the APOB region on chromosome 2. However, it should be noted that since ASSET fails to produce p-values for some of the SNPs due to computational issues, the list of Figure 3 presents the QQ plots corresponding to 5 3 0 the three methods.
We then compared the 17 genome-wide significant SNPs identified by pASTA(MA) to the 23 SNPs identified by another GWAS where all ten traits were analyzed jointly using a multivariate marginal association test (i.e. GEMMA) (Table S10 ). Seven SNPs belong to both lists, and the top five SNPs identified respectively by GEMMA and pASTA(MA) are the same (though in slightly different order). For rs2083637, ASSET and pASTA(MA) both identify TG and HDL as associated phenotypes (Table   4 ). However, both pASTA(JOINT) and pASTA(MA+CC) identify three additional phenotypes (CRP, TC, LDL), for which rs2083637 has significant interaction with BMI, when G-E interaction is taken 5 5 5
into account. Supplemental Figure S5 presents the effect and the corresponding 95% CIs for rs2083637 on CRP, TC, and LDL when BMI equals the mean, meanേ1 standard deviation (sd), and meanേ2sd.
We observe variation of the SNP effect sizes across different levels of BMI. For example, rs2083637 has positive but not significant effect on CRP for subjects with average BMI, while for subjects whose BMI is 2 sd greater than the average, the association becomes negative and significant at the level of 5 6 0 0.05. Therefore, the incorporation of G-E interaction can enhance the knowledge that is not available in marginal association testing. The overall p-value of associations given by pASTA(JOINT)
) is also smaller than those given by 1-df methods (2.7ൈ10 phenotypes. SNP rs754524 has been previously reported to be associated with both traits. [31, 32] .
ASSET identifies two additional phenotypes, glucose and HDL, and fails to identify TC. The evidence for the marginal association of this SNP with HDL is not strong [27] , which indicates that such identified association may be false. pASTA (JOINT) identifies the same set of associated traits as pASTA(MA). This example shows that by incorporating interactions one can obtain smaller p-values 5 7 0 for detecting overall associations and discover more relevant traits that are missed by ASSET, ones that show significant G-E interaction effects in phenotype-specific analysis.
Discussion
We propose a powerful subset-based framework for the analysis of association studies after accounting 5 7 5
for potential G-E interactions. Simulation studies demonstrate that this framework improves the power to detect overall associations as well as the accuracy of determining associated studies/traits by incorporating G-E interactions, while maintaining comparable power to ASSET in the absence of such interactions. Our data examples exemplify that 2-df pASTA yields smaller meta-analytic p-values for SNPs that show significant G-E interactions in study/phenotype-specific analysis compared to 1-df 5 8 0 methods where only marginal genetic associations are considered ( Table 3 and Table 4 ). In addition, our analysis on the NFBC1966 data illustrates that pASTA is able to identify new phenotypes that are associated with given susceptibility loci after considering G-E interactions that will be missed by traditional marginal association analysis ( Table 4 ). These properties make pASTA a powerful tool to identify candidate SNPs that are potentially associated with the trait(s) of interest in the screening step Crispr-Cas9 knockout screening can be carried out in human cell lines to determine the functional significance of these candidate SNPs [34] . 5 9 0
Our simulation studies show that in the presence of interaction, pASTA(MA+EB) has the best performance in terms of all four evaluation metrics in a case-control setting where G-E independence holds. The rest of the 2-df methods (Fisher's methods, pASTA[JOINT] and pASTA[MA+CC]) give similar power for detecting overall associations across the scenarios ( Figures 1B-1E ), but pASTA has 5 9 5
the advantage of being able to identify the subset of studies/traits that are most likely to contribute to the associations. For a cohort study with multiple phenotypes where the G-E independence does not apply, pASTA(JOINT) gives the best performance in terms of the four metrics (Figures 2E-2H ).
There are several limitations of our proposed approach that lend the problem to future research. The 6 0 0 present proposal for pASTA focuses on testing the existence of genetic associations using p-values as inputs and is purely bi-directional in nature. It aggregates the evidence of both genetic effects and G-E interactions from individual studies but does not specify the directions of such effects or interactions. It is a pure testing approach and does not provide pooled regression coefficient estimates from metaanalysis. Thus it loses insight into the nature of the environmental heterogeneity across cohorts. 6 0 5
Further work is needed to define the subsets of studies that have similar direction of genetic effects in subsets defined by the environmental factor (for example the sign of estimates correlations across the test statistics need to be taken into account, the average run times for both pASTA(MA) and pASTA(JOINT) for one SNP were 1.7 seconds. For a typical GWAS to analyze one million SNPs, the projected computation time of pASTA on 20 CPU cores is approximately one day.
ASSET was slightly faster than pASTA in the NFBC 1966 data analysis (1.5 seconds) but twice slower in the T2D data analysis (3.3 seconds). Computing time was calculated using the R package 6 2 5 microbenchmark [36] . We plan to optimize the pASTA implementation code and develop an efficient R package akin to ASSET. Appendix 6 3 0
Detailed Derivation of Meta-analytic p-value
For an observed test statistic
, the DLM approximated p-value can be expressed as 
. The last inequality is justified by the "separability" assumption that given the current subset, its neighbors have independent Z-statistics. Fisher's combined p-value method as if the true subset of non-null studies and the model from which data were generated were known a priori. The null hypothesis in gold standard depends on specific situations. In the presence and absence of G-E interaction, JOINT and MA were tested, respectively. Therefore, the statistical power is not comparable across scenarios. 
